MB

Michael Bailey

President and Chief Executive Officer

AVEO Oncology

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
AVEO Oncology
Industry
research
Employees
200.0
Seniority
C suite
Annual Revenue
94310000.0

Technologies

Outlook ServiceNow Microsoft Office 365 Amazon AWS Drupal Media Temple SSL WP Engine Google Font API Vimeo Bootstrap Framework Apache Google Analytics Google Tag Manager WordPress.org Mobile Friendly Remote

Keywords

oncology biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceutical treatment clinical trials renal cell carcinoma tivozanib fotivda immunotherapy cancer cachexia ficlatuzumab anti-hgf vegf tki monoclonal antibodies av-203 av-380 av-353 fda approval phase 3 study comparative analysis survival analysis drug development pipeline investigational drugs pharmaceutical collaborations market access oncology commercialization strategic partnerships tumor types patient support programs clinical data regulatory affairs cancer treatment solid tumors head & neck cancer advanced cancer research partnerships clinical development drug candidates preclinical studies immune checkpoint inhibitors medical information scientific advisory publications healthcare compliance targeted therapies life sciences biologics manufacturing patient outcomes oncology leadership market launch cancer treatments patient-centric lg chem innovative therapies quality of life unmet medical needs multiple myeloma global expansion healthcare professionals patient-focused science-driven differentiated solutions cancer patients advanced therapies collaborative culture experienced leadership therapeutic efficacy market positioning competitive landscape cancer community effective treatments innovative drug development hospital & health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans